Plasma Woes: Baxter Lay-Offs, $200 Mil. Charge Attributed To Competition
This article was originally published in The Gray Sheet
Executive Summary
Baxter expects to see annual declines of its plasma products inventory beginning in 2004, following a shift from "capacity expansion to capacity optimization," the firm said July 2
You may also be interested in...
Baxter Profit Pressures Lead To Expanded Restructuring, SEC Probe
Baxter expects to save $120-$160 mil. annually upon completion of a revised restructuring plan that includes the closure of 30 facilities and downsizing its workforce by 6%, or 3,200 employees
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.